emerging technologies

Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.

Jayme Strauss, Precision Neuroscience's chief clinical and commercial officer, kicks off the Emerging Technologies series, discussing how the company's brain-computer interface, Layer 7, works and what it hopes to accomplish for patients.

Augmented reality and virtual technologies are shaping innovative approaches in operating rooms, mental health care and patient monitoring.

Researchers will study how Rion’s Purified Exosome Product may aid service members with pulmonary disease via a collaboration with the U.S. Army Medical Research Institute and Mayo Clinic, says Dr. Atta Behfar, Rion’s CEO and cofounder.

Revolutionizing and democratizing healthcare take expertise and technology employed with a diverse mindset, says Dr. Nadine Hachach-Haram, Founder of Proximie.

The FDA gave De Novo clearance for AppliedVR's EaseVRx system to help with chronic lower back pain. CEO Matthew Stoudt introduces the technology and talks about what’s next for the digital therapeutic company.